nifedipine has been researched along with Polycystic Kidney Diseases in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, Y | 1 |
| Suzuki, H | 1 |
| Okada, H | 1 |
| Takenaka, T | 1 |
| Saruta, T | 1 |
| Schiffl, H | 1 |
1 trial available for nifedipine and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel B | 1996 |
1 other study available for nifedipine and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Platelet cytosolic free calcium concentration in hypertension associated with early stage kidney disease.
Topics: Adult; Blood Platelets; Calcium; Cytosol; Drug Therapy, Combination; Female; Glomerular Filtration R | 1989 |